Pfizer Reaches $5 Billion Deal With US For COVID-19 Treatment

The United States will pay pharmaceutical company Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if the FDA authorizes it. Pfizer requested the FDA to authorize the pill for emergency use on Tuesday. “With more than 5 million deaths and countless lives impacted by this devastating disease globally, there is an urgent need for life-saving treatment options,” Pfizer’s CEO, Albert Bourla, said in a statement Tuesday. “We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the US


